Georgia Tech and the Ovarian Cancer Institute develop early detection procedure
Wednesday, November 18, 2015
Posted by: Angela King
Georgia Tech collaborated with the Ovarian Cancer Institute to develop a way to detect ovarian cancer in its earliest stage.
Using a blood sample, a mass spectrometer and a computer algorithm, researchers and lab technicians can detect specific metabolite levels that indicate ovarian cancer.
“By the time ovarian cancer is detected, it’s usually too late,” said Dr. Benedict Benigno, founder and CEO of the Ovarian Cancer Institute and director of gynecologic oncology at Northside Hospital in Atlanta, said in a statement. “Existing screening methods such as pelvic examinations, ultrasounds and CA-125 blood tests are notoriously unreliable. It was so frustrating to encounter newly diagnosed patients, who had experienced symptoms for only a few weeks, in such advanced stages. We are thrilled to provide women with such a highly accurate test.”
Patients diagnosed with State 1 or Stage 2A ovarian cancer have a 90 percent survival rate, but the cancer is often diagnosed in later stages. Because of this, ovarian cancer is the number one cancer killer among U.S. women.
Georgia Tech and the Ovarian Cancer Institute also created one of the world's largest ovarian cancer tissue and serum banks.
The study was published in Nature's online journal "Scientific Reports" Nov. 17.
Source: Atlanta Business Chronicle. http://www.bizjournals.com/atlanta/news/2015/11/17/georgia-tech-and-the-ovarian-cancer-institute.html?ana=e_atl_rdup&s=newsletter&ed=2015-11-18&u=q1%2BEnOO0bIrUsLJdAILw9sm0LCi&t=1447858738